{"id":27404,"date":"2026-06-10T14:31:01","date_gmt":"2026-06-10T09:01:01","guid":{"rendered":"https:\/\/trending.niftytrader.in\/?p=27404"},"modified":"2026-06-10T14:32:32","modified_gmt":"2026-06-10T09:02:32","slug":"3-buyback-offers-close-today-final-hours","status":"publish","type":"post","link":"https:\/\/www.niftytrader.in\/markets\/3-buyback-offers-close-today-final-hours\/","title":{"rendered":"Final Hours for Investors as 3 Buyback Offers Close Today"},"content":{"rendered":"<p class=\"font-claude-response-body break-words whitespace-normal\"><strong>Three buyback offers worth a combined \u20b91,185 crore are shutting on Wednesday; here&#8217;s everything eligible shareholders need to know before the window closes.<\/strong><\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Key Takeaways<\/h2>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\">Buyback offers from <strong>Zydus Lifesciences<\/strong>, <strong>Dhanuka Agritech<\/strong>, and <strong>CyberTech Systems &amp; Software<\/strong> are closing today, June 10, 2026.<\/li>\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\">The three offers together are valued at approximately <strong>\u20b91,185 crore<\/strong>, with Zydus alone accounting for \u20b91,100 crore.<\/li>\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\">All three are <strong>tender-route buybacks<\/strong>; only shareholders who held shares on the respective May 2026 record dates are eligible; fresh positions do not qualify.<\/li>\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\">Dhanuka Agritech offers the steepest buyback premium at <strong>~29% over its last closing price<\/strong>.<\/li>\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\">Small shareholders get preferential entitlement ratios in all three offers, making this more accessible to retail investors.<\/li>\n<\/ul>\n<hr \/>\n<h2 class=\"bb-title\">Buyback Comparison \u2014 Closing June 10, 2026<\/h2>\n<div class=\"bb-sub\">All three offers close today via tender route<\/div>\n<table class=\"bb-table\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Buyback Price<\/th>\n<th>Premium vs CMP<\/th>\n<th>Total Size<\/th>\n<th>Small Shareholder Entitlement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/zyduslife.com\/\" rel=\"noopener\"><span class=\"company\">Zydus Lifesciences<\/span><\/a><br \/>\nPharma<\/td>\n<td>\u20b91,260<\/td>\n<td><span class=\"badge badge-amber\">~14% premium<\/span><\/td>\n<td><strong>\u20b91,100 Cr<\/strong><\/td>\n<td>5 shares per 49 held<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.dhanuka.com\/\" rel=\"noopener\"><span class=\"company\">Dhanuka Agritech<\/span><\/a><br \/>\nAgrochem<\/td>\n<td>\u20b91,400<\/td>\n<td><span class=\"badge badge-green\">~29% premium<\/span><\/td>\n<td>\u20b970 Cr<\/td>\n<td>1 share per 15 held<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/cybertech.com\/\" rel=\"noopener\"><span class=\"company\">CyberTech Systems<\/span><\/a><br \/>\nIT<\/td>\n<td>\u20b9170<\/td>\n<td><span class=\"badge badge-green\">~23% premium<\/span><\/td>\n<td>\u20b914.45 Cr<\/td>\n<td>12 shares per 277 held<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div>CMP data as of previous NSE closing. Record dates lapsed in May 2026, fresh positions not eligible.<\/div>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What Is a Share Buyback and Why Does It Matter to You?<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal\">A share buyback (or repurchase) is a corporate action where a company buys back its own equity from existing shareholders, typically at a price above the prevailing market rate. For eligible investors, this creates an opportunity to exit part of their holding at a guaranteed premium without impacting open-market prices.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Under the tender-route mechanism used by all three companies here, shareholders submit (or &#8220;tender&#8221;) a specified number of shares during the offer window. Acceptance is subject to entitlement ratios set by the company, and the <strong>small shareholder category<\/strong> (generally investors holding shares worth up to \u20b92 lakh on the record date) gets a reserved, more favourable quota.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\"><strong>Important:<\/strong> The record dates for all three buybacks have already lapsed in May 2026. Investors who bought shares after the record date are <strong>not eligible<\/strong> to participate, regardless of their current holding.<\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Zydus Lifesciences Buyback \u2014 \u20b91,100 Crore at \u20b91,260 per Share<\/h2>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Offer details<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Zydus Lifesciences is repurchasing <strong>87.3 lakh equity shares<\/strong> at a buyback price of <strong>\u20b91,260 per share<\/strong>, representing a premium of approximately <strong>14% over the NSE closing price of \u20b91,105.6<\/strong> on the previous trading session.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">This is the <strong>largest-ever buyback announced by Zydus Lifesciences<\/strong>, underscoring management&#8217;s confidence in the company&#8217;s cash generation and balance sheet strength.<\/p>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Entitlement ratio<\/h3>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\"><strong>Small shareholder category:<\/strong> 5 equity shares for every 49 shares held on the record date.<\/li>\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\"><strong>General category:<\/strong> 7 equity shares for every 937 shares held on the record date.<\/li>\n<\/ul>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Shareholding context<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Before the buyback announcement, promoters and promoter group entities held nearly <strong>75%<\/strong> of Zydus Lifesciences as of May 15, 2026. Retail investors and mutual funds each held around <strong>5%<\/strong>, foreign portfolio investors (FPIs) held approximately <strong>7%<\/strong>, and insurance companies held just over <strong>6%<\/strong>.<\/p>\n<p><strong>Check Live on Niftytrader:<\/strong> <a href=\"https:\/\/www.niftytrader.in\/options-max-pain-chart-live\/zyduslife\">ZYDUS LIFESCIENCES Max Pain Live Chart For NSE<\/a><\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Dhanuka Agritech Buyback \u2014 \u20b970 Crore at \u20b91,400 per Share<\/h2>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Offer details<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Dhanuka Agritech is buying back up to <strong>5 lakh shares<\/strong> at <strong>\u20b91,400 per share<\/strong> \u2014 a premium of nearly <strong>29% over the NSE closing price of \u20b91,087.10<\/strong>. At \u20b970 crore, this is the smallest of the three offers in absolute size, but the premium on offer is the most attractive of the lot.<\/p>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Entitlement ratio<\/h3>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\"><strong>Small shareholder category:<\/strong> 1 equity share for every 15 shares held on the record date.<\/li>\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\"><strong>General category:<\/strong> 5 equity shares for every 518 shares held on the record date.<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal\">The thin general-category entitlement (5 in 518) means the acceptance ratio for large holders is expected to be low. Small shareholders, by contrast, can tender 1 in every 15 shares, a comparatively generous ratio for a \u20b970 crore offer.<\/p>\n<p><strong>Check live on Niftytrader<\/strong>:<a href=\"https:\/\/www.niftytrader.in\/stocks-price\/dhanuka\/chart\"> DHANUKA AGRITECH Share Price Chart<\/a><\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">CyberTech Systems &amp; Software Buyback \u2014 \u20b914.45 Crore at \u20b9170 per Share<\/h2>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Offer details<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal\">CyberTech Systems &amp; Software is repurchasing <strong>8.5 lakh shares<\/strong>, representing <strong>9.81% of its total equity<\/strong>, at a buyback price of <strong>\u20b9170 per share<\/strong>. The aggregate buyback size is capped at \u20b914.45 crore. The offer price implies a premium of more than <strong>23% over the previous NSE closing price of \u20b9137.71<\/strong>.<\/p>\n<h3 class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Entitlement ratio<\/h3>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"font-claude-response-body whitespace-normal break-words pl-2\"><strong>Both small shareholder and general category:<\/strong> 12 equity shares for every 277 shares held on the record date.<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Unlike Zydus and Dhanuka, CyberTech has set the same entitlement ratio for both categories.<\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Should You Tender Your Shares?<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal\">A buyback is not a guaranteed full-exit opportunity. The entitlement ratio determines only how many shares you can tender; the actual acceptance depends on overall participation within each category. Here are the key considerations:<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\"><strong>Check your category first.<\/strong> If you held shares worth \u20b92 lakh or less (at issue price) on the record date, you likely qualify under the small shareholder quota, which typically has a higher acceptance probability.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\"><strong>Compare the premium against the current market price.<\/strong> If the stock is already trading near or above the buyback price in the open market, tendering may not be the better option.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\"><strong>Tax treatment matters.<\/strong> Buyback proceeds are subject to applicable tax rules. Consult a tax adviser to understand your post-tax realisation.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\"><strong>Untendered shares continue as normal.<\/strong> If your shares are not accepted, they are returned to your demat account automatically. Buyback participation carries no penalty for non-acceptance.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">[<strong>\u00a0Data CTA:<\/strong> Track FII-DII flows and open interest data for Zydus Lifesciences and other stocks in real time on the [<a href=\"https:\/\/niftytrader.in\/fii-dii-data\" rel=\"noopener\">NiftyTrader FII-DII Dashboard<\/a> \u2192]]<\/p>\n<hr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\" \/>\n<h2 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Bottom Line<\/h2>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Three corporate buybacks worth \u20b91,185 crore in aggregate are closing today, offering eligible shareholders a final window to tender shares at premiums ranging from 14% (Zydus) to 29% (Dhanuka).<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">Zydus Lifesciences dominates in deal size with its record \u20b91,100 crore offer, while Dhanuka Agritech leads on the premium percentage.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">All three offers are via the tender route, and only shareholders on the respective May 2026 record dates can participate.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">If you are eligible, today is the last opportunity; check your demat account entitlement and decide before the window shuts.<\/p>\n<hr \/>\n<p class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Disclaimer: <em>This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Please consult a SEBI-registered financial adviser before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Three buyback offers worth a combined \u20b91,185 crore are shutting on Wednesday; here&#8217;s everything eligible shareholders need to know before the window closes. Key Takeaways Buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems &amp; Software are closing today, June 10, 2026. The three offers together are valued at approximately \u20b91,185 crore, with Zydus [&hellip;]<\/p>\n","protected":false},"author":11,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[615],"tags":[2957,2952,2953,2954,1995,2956,2950,1668,2951,2955],"ppma_author":[1523],"class_list":["post-27404","post","type-post","status-publish","format-standard","has-post-thumbnail","category-stock-market-news","tag-buybackoffers","tag-corporateaction","tag-cybertech","tag-dhanukaagritech","tag-indianstocks","tag-sharebuyback","tag-shareholderupdate","tag-stockmarketnews","tag-tenderoffer","tag-zyduslifesciences"]," _eael_post_view_count":0,"authors":[{"term_id":1523,"user_id":11,"is_guest":0,"slug":"nikki","display_name":"Nikki Lodha","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/ae2e265bd56e0e890c866fbaa55d29846ba20cc5372adf666652268816af117e?s=96&d=mm&r=g","first_name":"Nikki","last_name":"Lodha","user_url":"https:\/\/www.niftytrader.in\/markets\/","author_category":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/27404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/comments?post=27404"}],"version-history":[{"count":1,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/27404\/revisions"}],"predecessor-version":[{"id":27406,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/27404\/revisions\/27406"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media\/27405"}],"wp:attachment":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media?parent=27404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/categories?post=27404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/tags?post=27404"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/ppma_author?post=27404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}